Your browser doesn't support javascript.
loading
GNRI Sustainability during One Cycle of First-Line Chemotherapy as a Prognostic Indicator in Patients with Metastatic Urothelial Carcinoma.
Sugiyama, Yosuke; Naiki, Taku; Tasaki, Yoshihiko; Mimura, Yoshihisa; Etani, Toshiki; Noda, Yusuke; Nozaki, Satoshi; Shimizu, Nobuhiko; Banno, Rika; Nagai, Takashi; Isobe, Teruki; Ando, Ryosuke; Moritoki, Yoshinobu; Kataoka, Tomoya; Odagiri, Kunihiro; Aoki, Maria; Gonda, Masakazu; Yasui, Takahiro; Hibi, Yoko.
Affiliation
  • Sugiyama Y; Department of Pharmacy, Nagoya City University Hospital, Nagoya, Japan.
  • Naiki T; Department of Nephro-urology, Graduate School of Medical Sciences, Nagoya City University, Nagoya, Japan.
  • Tasaki Y; Department of Pharmacy, Nagoya City University Hospital, Nagoya, Japan.
  • Mimura Y; Department of Pharmacy, Nagoya City University Hospital, Nagoya, Japan.
  • Etani T; Department of Nephro-urology, Graduate School of Medical Sciences, Nagoya City University, Nagoya, Japan.
  • Noda Y; Department of Urology, Toyota Kosei Hospital, Toyota, Japan.
  • Nozaki S; Department of Urology, Anjo Kosei Hospital, Anjo, Japan.
  • Shimizu N; Department of Urology, Anjo Kosei Hospital, Anjo, Japan.
  • Banno R; Department of Urology, Konan Kosei Hospital, Konan, Japan.
  • Nagai T; Department of Pharmacy, Nagoya City University Hospital, Nagoya, Japan.
  • Isobe T; Department of Pharmacy, Nagoya City University Hospital, Nagoya, Japan.
  • Ando R; Department of Pharmacy, Nagoya City University Hospital, Nagoya, Japan.
  • Moritoki Y; Department of Urology, Toyokawa Hospital, Aichi, Japan.
  • Kataoka T; Department of Pharmacology, Kataoka's Lab, Graduate School of Pharmaceutical Sciences, Chiba Institute of Science, Choshi, Japan.
  • Odagiri K; Department of Pharmacy, Nagoya City University Hospital, Nagoya, Japan.
  • Aoki M; Department of Nephro-urology, Graduate School of Medical Sciences, Nagoya City University, Nagoya, Japan.
  • Gonda M; Department of Nephro-urology, Graduate School of Medical Sciences, Nagoya City University, Nagoya, Japan.
  • Yasui T; Department of Nephro-urology, Graduate School of Medical Sciences, Nagoya City University, Nagoya, Japan.
  • Hibi Y; Department of Pharmacy, Nagoya City University Hospital, Nagoya, Japan.
Oncology ; 101(4): 224-233, 2023.
Article in En | MEDLINE | ID: mdl-36689919

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Urinary Bladder Neoplasms / Carcinoma, Transitional Cell Type of study: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Aged / Humans Language: En Journal: Oncology Year: 2023 Type: Article Affiliation country: Japan

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Urinary Bladder Neoplasms / Carcinoma, Transitional Cell Type of study: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Aged / Humans Language: En Journal: Oncology Year: 2023 Type: Article Affiliation country: Japan